Stay updated on Omalizumab in CRSwNP: Extension Study Clinical Trial
Sign up to get notified when there's something new on the Omalizumab in CRSwNP: Extension Study Clinical Trial page.

Latest updates to the Omalizumab in CRSwNP: Extension Study Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.4.2 is now displayed, replacing Revision: v3.4.1.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0. No visible changes to study details or page layout were observed.SummaryDifference0.0%

- Check47 days agoChange DetectedMinor formatting and textual edits across sections with no changes to core trial data (eligibility criteria, outcomes, or participating sites). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page shows a new Revision: v3.3.4, replacing the previous Revision: v3.3.3. This appears to be a minor site revision and does not alter study content or functionality.SummaryDifference0.0%

- Check83 days agoChange DetectedThe Study Locations section was updated with new sites across the US, Canada, Spain, and several European and former Soviet regions, and some previously listed locations were removed.SummaryDifference2%

Stay in the know with updates to Omalizumab in CRSwNP: Extension Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Omalizumab in CRSwNP: Extension Study Clinical Trial page.